Risk factors for multidrug resistance in tuberculosis patients with diabetes mellitus

BMC Infect Dis. 2022 Nov 11;22(1):835. doi: 10.1186/s12879-022-07831-3.

Abstract

Objective: To study the risk factors and prediction models of multidrug resistance in patients with tuberculosis and diabetes and those with a history of tuberculosis treatment.

Methods: A total of 256 tuberculosis patients with diabetes who were registered in Luoyang city, Henan Province, from January 2018 to December 2021. Logistic regression analysis was performed to analyse the risk factors for multidrug resistance. ROC curves were used to analyse the predictive model for multidrug resistance.

Results: Age < 65 years old, HbA1c, and a history of tuberculosis treatment were independent risk factors for multidrug resistance in patients with tuberculosis and diabetes (P < 0.05). The area under the ROC curve of predictive model for MDR was 0.878 (95% CI (0.824, 0.932)). Age < 65 years old and HbA1c were independent risk factors for MDR in patients with TB and diabetes with a history of TB treatment. The area under the ROC curve of predictive model for MDR was 0.920 [95% CI (0.831, 0.999)].

Conclusion: The predictive model had certain prediction value for the risk of multidrug resistance in patients with tuberculosis and diabetes.

Keywords: Diabetes; Multidrug resistant; Prediction model; Risk factors; Tuberculosis.

MeSH terms

  • Aged
  • Antitubercular Agents / pharmacology
  • Antitubercular Agents / therapeutic use
  • Diabetes Mellitus* / drug therapy
  • Diabetes Mellitus* / epidemiology
  • Drug Resistance, Multiple
  • Glycated Hemoglobin
  • Humans
  • Mycobacterium tuberculosis*
  • Risk Factors
  • Tuberculosis* / complications
  • Tuberculosis* / drug therapy
  • Tuberculosis* / epidemiology
  • Tuberculosis, Multidrug-Resistant* / complications
  • Tuberculosis, Multidrug-Resistant* / drug therapy
  • Tuberculosis, Multidrug-Resistant* / epidemiology

Substances

  • Glycated Hemoglobin A
  • Antitubercular Agents